Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: Impact of filtration timing

Transfusion

Volumn 40, Issue 7, 2000, Pages 781-788

  Ferrer, F ^a   Rivera, J ^a   Corral, J ^a   Gonzalez Conejero, R ^a   Lozano, M L ^a   Vicente, V ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE CONCENTRATE;

ALLOIMMUNIZATION; ARTICLE; COMPLEX FORMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FILTRATION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION; VIRUS TRANSMISSION;

BLOOD PRESERVATION; FILTRATION; HUMANS; PLATELET TRANSFUSION; PLATELETPHERESIS; TIME FACTORS;

EID: 0033855858     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40070781.x     Document Type: Article

References (37)

1. How should the safety and efficacy of platelet transfusions be assured?
2. Leukocyte-reduced blood products
3. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group
4. The role of cytokines in blood transfusion reactions
5. Increased tumor necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNFα and IL-6 levels and febrile transfusion reactions
6. The role of the plasma from platelet concentrates in transfusion reactions
7. Platelet transfusion practice: Time for renewed consensus (editorial)
8. Effect of prestorage WBC removal on the cytokine levels in stored platelet concentrates
9. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage
10. The use and quality control of WBC-depleted cell concentrates
11. Quality of blood components filtered before storage and at the bedside: Implications for transfusion practice
12. Removal of soluble biologic response modifiers (complement and chemokines) by a bedside white cell-reduction filter
13. Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters
14. Adsorption of anaphylatoxins and platelet-specific proteins by filtration of platelet concentrates with a polyester WBC reduction filter
15. Cytokine levels in platelet concentrates: Quantitation by bioassays and immunoassays
16. Complement activation during storage of single-donor platelet concentrates
17. Stability of glycoproteins Ib/IX and IIb/IIIa during preparation and storage of platelet concentrates: Detection by binding assays with epitope-defined monoclonal antibodies and physiological ligands
18. Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin
19. Benefit of prestorage WBC depletion of single-donor platelet concentrates
20. Platelet transfusion
21. Early WBC depletion of cellular blood components reduces red blood cell and platelet storage lesions
22. Effect of white cells on platelets during storage
23. Prestorage inline filtration of whole blood for obtaining white cell-reduced blood components
24. Platelet activation and thrombin generation in the obtention of platelets for transfusion
25. Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor α, and leukotriene B4
26. Febrile reactions to platelet transfusion: The effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method
27. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets
28. Chemokines in stored platelet concentrates
29. Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure
30. Anaphylatoxins in fresh-frozen plasma
31. Complement activation during storage of whole blood, red cells, plasma, and buffy coat
32. Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and WBC depletion
33. Partial purification of an immunosuppressive protein from a human tumor cell line and analysis of its relationship to transforming growth factor beta
34. Accumulation of the cytokines TGF-β1 and RANTES in stored platelet concentrates
35. Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-β1 in apheresis platelet concentrates during storage